top of page



See what matters

Used in 5,000+ lab settings

Secure & accessible data

Instant results & notifications

SMS & web accessible


Our Solutions Span Every Network and Every Communication Protocol

Aspect integrates with diagnostic devices to bring test results to clinicians, partners, and program staff through a private and secure communications network and extremely flexible reporting mechanisms. Aspect transparently handles everything from communicating test results to monitoring instrument operations. Patients can even be alerted when results are available.



Better Disease Intelligence for Better Disease Management

Aspect connects lab devices to allow diagnostic result tracking for TB, HIV, HCV, SARS-CoV-2, Ebola, Zika and other diseases. The system automates and sends custom notifications for summary test results and trends, commodities management, error rates, utilization rates, and more. Notifications are sent via SMS or email, and automated reports are sent to multiple recipients on demand or on your schedule.

Designed for simple, rapid deployment, Aspect works with local systems and may be hosted on SystemOne's secure, reliable servers, or locally.

Our operational dashboard allows you to manage devices, staff, inventory and site performance using accurate real time data



Modern Technology For Scalability And Integration

Aspect is optimized to communicate healthcare data in infrastructure-challenged and fully modernized settings. Every diagnostic device in a country can be connected via cellular data networks using smart 2G/3G routers for rapid and secure data transmission. Results and analyses are delivered to the healthcare team via internet, cellular data network, and SMS.

Aspect is disease and device agnostic, so you can add data streams to Aspect as they become available. For instance, if a new device is installed in a lab, or your program needs to add a disease stream for comparative purposes or co-infection monitoring, or if you want to add climate or agricultural data.

Manage Results Automatically

Deliver diagnostic results to clinician, supervisor, and ministry.

Collect and protect patient data (age, sex, reason for test, and more).

Link diagnosis to treatment through custom patient fields.

Deliver Data + Analysis to Streamline Programs

Generate and deliver disease summary and diagnostic reports automatically.

Integrate with national LIS, LIMS, DHS-2 to streamline data capture and use.

Monitor quality and performance.

Monitor Supplies + Device Performance

Monitor supplies and disposables by lab.

Manage inventory stock and transfers between location.

Analyze consumption rates by site.

Forecast consumable needs.

Record maintenance requests, service and repairs.

Analyze utilization and errors.


  • Shouldn’t we just build this ourselves?
    Ideally, all diagnostic devices and communications networks would be “plug and play.” But SystemOne had to raise millions of dollars to create a system that could work in any country and handle a wide range of telecommunications networks, device protocols, changing data requirements and program requirements. It also needed to function through power outages, equipment failures and human failures. We share this only to communicate the fact that setting up a digital infrastructure for diagnostics is difficult and expensive. SystemOne recovers fractions of these invested dollars with each project it implements, and the recipient countries each benefit from the large investment we made. We took this path because we believe it is prohibitively expensive and complicated to do this in each country separately, and such an approach would lead to numerous, heterogenous and unsustainable systems across many countries.
  • What if a country exceeds its expected usage?
    With per-test pricing, our annual fees are based upon the expected number of tests a country or program plans to procure and use. Beyond that, we do not enforce "license limits." Using a "per test" cost allocation method generally works out on both sides and avoids continually changing expectations on costs, which is hard for a program to sustain, and would be difficult and costly for our customers (and us) to manage.
  • Is there a minimum?
    Yes. We set a base level fee because there is a minimum level of effort to support each unique instance (country or program) of the software and to administer a contract. This is independent of the number of tests conducted or network usage. At this point, our minimum fee to set up and run connectivity in a country or for a health program is $50,000 .
  • Shouldn't connectivity come with the devices?
    In an ideal world, yes, and some device manufacturers include a digital offering with their devices. But they have no expertise in making information move in different countries and ensuring it gets to the right people at the right time. They are also not talented at making sure their instrument information is interoperable with other sources of data, which is incredibly important when dealing with multiple systems and multiple diseases. Most importantly, no country or program should be stuck with one device manufacturer’s digital platform. What if you want to change devices? Or what if you need to see information they might not willingly reveal, such as error rates and malfunctions? Or what if a health program needs to combine information from different manufacturers' diagnostic devices? For these reasons and many others, a multi-device, multi-disease platform is most useful.
  • How can I budget the cost of connectivity?
    Connectivity usually costs between 4% and 6% of the cost of diagnostics, and of course this can vary. But in general, this is a good percentage to keep in mind when budgeting. It is also a fraction of what a connectivity-enabled system will save in terms of inventory, re-testing, loss-to-follow-up, and optimizing numerous other parts of the diagnostic network.
  • If my program grows enormously, will my costs?
    This is a good question, and this concern is shared across many countries and programs. To state the concern differently: “what if I test 10 billion samples in a few years - will connectivity cost me $12 billion (assuming $1.20 per sample), and isn’t that unsustainable?" But it actually works the opposite way: Because we index our fees to the number of tests anticipated, as that number grows across the world, our fees will diminish proportionally. This is true whether we do per-test pricing or use a different method -- economies of scale will in time reduce the cost of the systems we sell. Currently, our service and support grow in proportion to the amount of testing that's performed, but we can already see that eventually they will level off and then diminish in proportion to the tests performed -- that's one of the advantages of working across numerous countries and encountering similar challenges.

*GxAlert is not associated with Cepheid nor Cepheid instrument systems, including GeneXpert® instruments.


Aspect Software Platform

bottom of page